{"rows":[{"id":5984,"title":"Psychedelics restructure information in the human brain","authors":"Blackburne, G.; Liardi, A.; Mallaroni, P.; McAlpine, R.; Carhart-Harris, R.; Timmermann, C.; Muthukumaraswamy, S. D.; Skipper, J. I.; Mediano, P. A. M.","journal":"bioRxiv","publication_date":"2026-10-08","publication_year":2026,"doi":"10.64898/2026.10.01.755915","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.10.01.755915","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"bioRxiv","publication_status":"preprint","date_added":"2026-10-09 01:23:29","last_checked":"2026-10-09 01:23:29","bibtex":null,"source_record_id":"DOI:10.64898/2026.10.01.755915","abstract_available":true,"abstract_source":"bioRxiv","abstract_source_url":"https://doi.org/10.64898/2026.10.01.755915","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"bioRxiv","source_record_id":"DOI:10.64898/2026.10.01.755915","source_url":"https://doi.org/10.64898/2026.10.01.755915","doi":"10.64898/2026.10.01.755915","pmid":"","publication_date":"2026-10-08","importer_version":"2.1.3","text_redistributed":false}},{"id":5710,"title":"Prospective real-world evidence of mental health outcomes following supervised psilocybin services within Oregons state-regulated model","authors":"Gow, A.; Shih, E.; Reid, R.; Qian, J. J.; Mellor, C.; McInnes, L. A.; Carhart-Harris, R.; Davis, J. N.","journal":"medRxiv","publication_date":"2026-08-19","publication_year":2026,"doi":"10.64898/2026.02.18.26346580","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.02.18.26346580","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Wellbeing,Observational Study","study_type":"Observational Study","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-07-11 19:28:11","last_checked":"2026-08-26 01:21:34","bibtex":null,"source_record_id":"DOI:10.64898/2026.02.18.26346580","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.02.18.26346580","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.02.18.26346580","source_url":"https://doi.org/10.64898/2026.02.18.26346580","doi":"10.64898/2026.02.18.26346580","pmid":"","publication_date":"2026-08-19","importer_version":"2.1.3","text_redistributed":false}},{"id":5676,"title":"Psilocybin therapy for adult females with anorexia nervosa: pilot study","authors":"Douglass Hannah M., Spriggs Meg J., Godfrey Kate, Danby Jennifer L., de Magalhaes Frederico J. C., Macdonald Lauren, Alderton Kirsty L., Archer Stephanie, Ahmad Kirran, Martell Jonny, Frias Jennifer T., Sawicka Gabriela, Read Tim, Blemings Allan, Lafrance Adele, Nicholls Dasha, Erritzoe David, Park Rebecca J., Nutt David J., Carhart-Harris Robin L.","journal":"The British Journal of Psychiatry","publication_date":"2026-07-08","publication_year":2026,"doi":"10.1192/bjp.2026.10687","pubmed_id":"42414058","openalex_id":"https://openalex.org/W7167587921","source_url":"https://doi.org/10.1192/bjp.2026.10687","substance_tags":"psilocybin","topic_tags":"Eating Disorders,Headache / Migraine,Clinical Trial,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-07-08 01:20:22","last_checked":"2026-08-09 08:28:46","bibtex":null,"source_record_id":"PMID:42414058","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1192/bjp.2026.10687","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42414058","source_url":"https://doi.org/10.1192/bjp.2026.10687","doi":"10.1192/bjp.2026.10687","pmid":"42414058","publication_date":"2026-07-08","importer_version":"2.1.3","text_redistributed":false}},{"id":5333,"title":"P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybin","authors":"Robin Carhart-Harris, David Erritzøe, James Stone, Rjs Wise, David Nutt","journal":"European Neuropsychopharmacology","publication_date":"2011-08-07","publication_year":2011,"doi":"10.1016/s0924-977x(11)70495-3","pubmed_id":null,"openalex_id":"https://openalex.org/W2061147949","source_url":"https://doi.org/10.1016/s0924-977x(11)70495-3","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Cancer Patients","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:05","last_checked":"2026-08-09 08:25:54","bibtex":null,"source_record_id":"DOI:10.1016/s0924-977x(11)70495-3","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/s0924-977x(11)70495-3","source_url":"https://doi.org/10.1016/s0924-977x(11)70495-3","doi":"10.1016/s0924-977x(11)70495-3","pmid":"","publication_date":"2011-08-07","importer_version":"2.1.3","text_redistributed":false}},{"id":5309,"title":"PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS","authors":"Robin Carhart-Harris","journal":"Journal of Neurology Neurosurgery & Psychiatry","publication_date":"2013-08-06","publication_year":2013,"doi":"10.1136/jnnp-2013-306103.17","pubmed_id":null,"openalex_id":"https://openalex.org/W2003006205","source_url":"https://doi.org/10.1136/jnnp-2013-306103.17","substance_tags":"psilocybin","topic_tags":"Anxiety,End-of-Life Distress,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Personality Change,Spirituality,Mystical Experience,Review Article,Healthy Volunteers,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:04","last_checked":"2026-08-09 08:25:54","bibtex":null,"source_record_id":"DOI:10.1136/jnnp-2013-306103.17","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1136/jnnp-2013-306103.17","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1136/jnnp-2013-306103.17","source_url":"https://doi.org/10.1136/jnnp-2013-306103.17","doi":"10.1136/jnnp-2013-306103.17","pmid":"","publication_date":"2013-08-06","importer_version":"2.1.3","text_redistributed":false}},{"id":5202,"title":"Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression","authors":"Rosalind Watts, Camilla Day, Jacob Krzanowski, David Nutt, Robin Carhart-Harris","journal":"Journal of Humanistic Psychology","publication_date":"2017-06-19","publication_year":2017,"doi":"10.1177/0022167817709585","pubmed_id":null,"openalex_id":"https://openalex.org/W2644260506","source_url":"https://doi.org/10.1177/0022167817709585","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Emotional Processing,Treatment-Resistant Depression","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:02","last_checked":"2026-08-09 08:25:51","bibtex":null,"source_record_id":"DOI:10.1177/0022167817709585","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1177/0022167817709585","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1177/0022167817709585","source_url":"https://doi.org/10.1177/0022167817709585","doi":"10.1177/0022167817709585","pmid":"","publication_date":"2017-06-19","importer_version":"2.1.3","text_redistributed":false}},{"id":5157,"title":"Serotonin, psychedelics and psychiatry","authors":"Robin Carhart-Harris","journal":"World Psychiatry","publication_date":"2018-09-07","publication_year":2018,"doi":"10.1002/wps.20555","pubmed_id":"30192100","openalex_id":"https://openalex.org/W2891343109","source_url":"https://doi.org/10.1002/wps.20555","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Randomized Controlled Trial,Safety","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:01","last_checked":"2026-08-09 08:25:50","bibtex":null,"source_record_id":"PMID:30192100","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1002/wps.20555","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:30192100","source_url":"https://doi.org/10.1002/wps.20555","doi":"10.1002/wps.20555","pmid":"30192100","publication_date":"2018-09-07","importer_version":"2.1.3","text_redistributed":false}},{"id":5049,"title":"Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey","authors":"Joanna Kuc, Hannes Kettner, Fernando E. Rosas, David Erritzøe, Eline Haijen, Mendel Kaelen, David Nutt, Robin Carhart-Harris","journal":"Psychopharmacology","publication_date":"2021-11-03","publication_year":2021,"doi":"10.1007/s00213-021-05999-1","pubmed_id":"34734314","openalex_id":"https://openalex.org/W3208662682","source_url":"https://doi.org/10.1007/s00213-021-05999-1","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Consciousness,Emotional Processing,Mystical Experience,Observational Study,Toxicity,Drug Interactions","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-07-04 06:51:58","bibtex":null,"source_record_id":"PMID:34734314","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1007/s00213-021-05999-1","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:34734314","source_url":"https://doi.org/10.1007/s00213-021-05999-1","doi":"10.1007/s00213-021-05999-1","pmid":"34734314","publication_date":"2021-11-03","importer_version":"2.1.3","text_redistributed":false}},{"id":5038,"title":"P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot study","authors":"Hannah Douglass, Meg J. Spriggs, R.J. Park, Tim Read, Jennifer L. Danby, Frederico José Coelho de Magalhães, Kirsty L. Alderton, Adèle Lafrance, Dasha Nicholls, David Erritzøe, David Nutt, Robin Carhart-Harris","journal":"European Neuropsychopharmacology","publication_date":"2021-12-01","publication_year":2021,"doi":"10.1016/j.euroneuro.2021.10.335","pubmed_id":null,"openalex_id":"https://openalex.org/W4200393290","source_url":"https://doi.org/10.1016/j.euroneuro.2021.10.335","substance_tags":"psilocybin","topic_tags":"Eating Disorders,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:44","bibtex":null,"source_record_id":"DOI:10.1016/j.euroneuro.2021.10.335","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.euroneuro.2021.10.335","source_url":"https://doi.org/10.1016/j.euroneuro.2021.10.335","doi":"10.1016/j.euroneuro.2021.10.335","pmid":"","publication_date":"2021-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5033,"title":"P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to music","authors":"Matthew B. Wall, Cynthia Lam, Natalie Ertl, Mendel Kaelen, Leor Roseman, David Nutt, Robin Carhart-Harris","journal":"European Neuropsychopharmacology","publication_date":"2021-12-01","publication_year":2021,"doi":"10.1016/j.euroneuro.2021.10.741","pubmed_id":null,"openalex_id":"https://openalex.org/W4200025628","source_url":"https://doi.org/10.1016/j.euroneuro.2021.10.741","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:44","bibtex":null,"source_record_id":"DOI:10.1016/j.euroneuro.2021.10.741","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.euroneuro.2021.10.741","source_url":"https://doi.org/10.1016/j.euroneuro.2021.10.741","doi":"10.1016/j.euroneuro.2021.10.741","pmid":"","publication_date":"2021-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4927,"title":"Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational Study","authors":"Gomathi Saminathan, Kavitha Kandasamy, Savitha Navaneethakrishnan, Mohana Ashokkumar, Brindha Veerappan, Krishnamoorthy Bellie Sundaram, G Aghajanian, G Marek, J.-C Bque, M Imad, L Mladenovic, J Gingrich, R Andrade, R Glennon, J Rosecrans, R Young, C Krumhansl, E Kessler, D Nichols, Psychedelics, Hallucinogens, P Delgado, F Moreno, C Nichols, B Liester, R Strassman, L Roseman, L Demetriou, M Wall, D Nutt, R Carhart-Harris, B Krishnamoorthy, S Kahlal, S Ghosh, J.-F Halet, Electronic, A Thakur, K Chakrahari, S Bose, P Hamon, T Roisnel, B Le Guennic, J.-Y Saillard, K Geetharani, S Mobin, F Neese, A Sherwood, R Kargbo, K Kaylo, N Cozzi, P Meisenheimer, J Kaduk, J Daniel, M Haberman, T Prisinzano, P Cumming, M Scheidegger, D Dornbierer, M Palner, B Quednow, C Martin-Soelch, A Rickli, O Moning, M Hoener, M Liechti, M Madsen, D Stenbaek, A Arvidsson, S Armand, M Marstrand-Joergensen, S Johansen, K Linnet, B Ozenne, G Knudsen, P Fisher, E Pottie, O Kupriyanova, A Brandt","journal":"Letters in Applied NanoBioScience","publication_date":"2022-09-17","publication_year":2022,"doi":"10.33263/lianbs124.105","pubmed_id":null,"openalex_id":"https://openalex.org/W4308468771","source_url":"https://doi.org/10.33263/lianbs124.105","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:56","last_checked":"2026-08-09 08:25:40","bibtex":null,"source_record_id":"DOI:10.33263/lianbs124.105","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.33263/lianbs124.105","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.33263/lianbs124.105","source_url":"https://doi.org/10.33263/lianbs124.105","doi":"10.33263/lianbs124.105","pmid":"","publication_date":"2022-09-17","importer_version":"2.1.3","text_redistributed":false}},{"id":4866,"title":"Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up results","authors":"Hannah Douglass, Merle Spriggs, Kate Godfrey, Jennifer L. Danby, Francisco Magalhães, Kirsty L. Alderton, Liane Macdonald, Stephanie Archer, Tim Read, Adèle Lafrance, Dasha Nicholls, David Erritzøe, R. Park, David Nutt, Robin Carhart-Harris","journal":"Neuroscience Applied","publication_date":"2023-01-01","publication_year":2023,"doi":"10.1016/j.nsa.2023.102878","pubmed_id":null,"openalex_id":"https://openalex.org/W4390223843","source_url":"http://dx.doi.org/10.1016/j.nsa.2023.102878","substance_tags":"psilocybin","topic_tags":"Eating Disorders","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-08-09 08:25:38","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2023.102878","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2023.102878","source_url":"http://dx.doi.org/10.1016/j.nsa.2023.102878","doi":"10.1016/j.nsa.2023.102878","pmid":"","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4712,"title":"Psilocybin vs Escitalopram for depression: 6-month follow-up","authors":"Thomas Barba, David Erritzøe, Kyle T. Greenway, Rinki Murphy, John Martell, Christopher Timmermann, Ashleigh Murphy-Beiner, Bruna Giribaldi, Michelle Baker Jones, Brandon Weiss, Robin Carhart-Harris","journal":"Neuroscience Applied","publication_date":"2024-01-01","publication_year":2024,"doi":"10.1016/j.nsa.2024.104377","pubmed_id":null,"openalex_id":"https://openalex.org/W4405637013","source_url":"https://doi.org/10.1016/j.nsa.2024.104377","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:44","last_checked":"2026-08-09 08:25:32","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2024.104377","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2024.104377","source_url":"https://doi.org/10.1016/j.nsa.2024.104377","doi":"10.1016/j.nsa.2024.104377","pmid":"","publication_date":"2024-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4667,"title":"Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder","authors":"Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, David Erritzøe","journal":"International Journal of Mental Health and Addiction","publication_date":"2024-03-07","publication_year":2024,"doi":"10.1007/s11469-024-01253-9","pubmed_id":null,"openalex_id":"https://openalex.org/W4392550813","source_url":"https://doi.org/10.1007/s11469-024-01253-9","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Mystical Experience,Clinical Trial,Treatment-Resistant Depression","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-08-09 08:25:30","bibtex":null,"source_record_id":"DOI:10.1007/s11469-024-01253-9","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1007/s11469-024-01253-9","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1007/s11469-024-01253-9","source_url":"https://doi.org/10.1007/s11469-024-01253-9","doi":"10.1007/s11469-024-01253-9","pmid":"","publication_date":"2024-03-07","importer_version":"2.1.3","text_redistributed":false}},{"id":4572,"title":"Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression","authors":"Gustavo Deco, Yonatan Sanz Perl, Samuel Johnson, Niamh Bourke, Robin Carhart-Harris, Morten L. Kringelbach","journal":"Nature Mental Health","publication_date":"2024-08-05","publication_year":2024,"doi":"10.1038/s44220-024-00298-y","pubmed_id":null,"openalex_id":"https://openalex.org/W4401339608","source_url":"https://doi.org/10.1038/s44220-024-00298-y","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:42","last_checked":"2026-08-09 08:25:27","bibtex":null,"source_record_id":"DOI:10.1038/s44220-024-00298-y","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1038/s44220-024-00298-y","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1038/s44220-024-00298-y","source_url":"https://doi.org/10.1038/s44220-024-00298-y","doi":"10.1038/s44220-024-00298-y","pmid":"","publication_date":"2024-08-05","importer_version":"2.1.3","text_redistributed":false}},{"id":4475,"title":"Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depression","authors":"Rebecca Harding, Natalie Ertl, Rabia Zafar, Magnus Wall, Rajkanya Das, David Erritzøe, David Nutt, Robin Carhart-Harris","journal":"Neuroscience Applied","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1016/j.nsa.2025.105421","pubmed_id":null,"openalex_id":"https://openalex.org/W4408526135","source_url":"https://doi.org/10.1016/j.nsa.2025.105421","substance_tags":"psilocybin","topic_tags":"Depression,Brain Imaging","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:41","last_checked":"2026-08-09 08:25:24","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.105421","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.105421","source_url":"https://doi.org/10.1016/j.nsa.2025.105421","doi":"10.1016/j.nsa.2025.105421","pmid":"","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4303,"title":"A lexicon for psychedelic research and treatment","authors":"David Nutt, David Erritzøe, Anne Katrin Schlag, David Luke, Deborah C. Mash, Hiroyuki Uchida, Jacob S. Aday, James Rucker, Liliana Galindo, Mark Sweeney, Matthew X. Lowe, Oliver Davis, Plinio Ferreira, Rayyan Zafar, Robin Carhart-Harris, Tadeusz Hawrot, Joanna C. Neill","journal":"Drug Science Policy and Law","publication_date":"2025-08-31","publication_year":2025,"doi":"10.1177/20503245251380511","pubmed_id":null,"openalex_id":"https://openalex.org/W4414407628","source_url":"https://doi.org/10.1177/20503245251380511","substance_tags":"psilocybin","topic_tags":"Depression,Pharmacology,Microdosing,Clinical Trial,Treatment-Resistant Depression,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:39","last_checked":"2026-07-04 07:00:33","bibtex":null,"source_record_id":"DOI:10.1177/20503245251380511","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1177/20503245251380511","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1177/20503245251380511","source_url":"https://doi.org/10.1177/20503245251380511","doi":"10.1177/20503245251380511","pmid":"","publication_date":"2025-08-31","importer_version":"2.1.3","text_redistributed":false}},{"id":4244,"title":"Correction: Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology","authors":"Kenneth Shinozuka, Katarina Jerotic, Pedro A. M. Mediano, A ZHAO, Katrin H. Preller, Robin Carhart-Harris, Morten L. Kringelbach","journal":"Translational Psychiatry","publication_date":"2025-11-12","publication_year":2025,"doi":"10.1038/s41398-025-03731-7","pubmed_id":"41233360","openalex_id":"https://openalex.org/W4416194041","source_url":"https://doi.org/10.1038/s41398-025-03731-7","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Pharmacology,Consciousness,Aging,Meta-Analysis,Systematic Review,Review Article,Toxicity","study_type":"Meta-Analysis","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:38","last_checked":"2026-07-04 07:00:33","bibtex":null,"source_record_id":"PMID:41233360","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1038/s41398-025-03731-7","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:41233360","source_url":"https://doi.org/10.1038/s41398-025-03731-7","doi":"10.1038/s41398-025-03731-7","pmid":"41233360","publication_date":"2025-11-12","importer_version":"2.1.3","text_redistributed":false}},{"id":4052,"title":"Classic psychedelics in obsessive-compulsive disorder: a circuit-based framework","authors":"Saif S. Ali, Robin L. Carhart-Harris, Karl G. Sieg","journal":"Nature Mental Health","publication_date":"2026-03-31","publication_year":2026,"doi":"10.1038/s44220-026-00626-4","pubmed_id":null,"openalex_id":"https://openalex.org/W7146946836","source_url":"https://doi.org/10.1038/s44220-026-00626-4","substance_tags":"psilocybin","topic_tags":"Addiction,OCD,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:35","last_checked":"2026-07-04 06:34:35","bibtex":null,"source_record_id":"DOI:10.1038/s44220-026-00626-4","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1038/s44220-026-00626-4","source_url":"https://doi.org/10.1038/s44220-026-00626-4","doi":"10.1038/s44220-026-00626-4","pmid":"","publication_date":"2026-03-31","importer_version":"2.1.3","text_redistributed":false}},{"id":3905,"title":"P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression","authors":"Laura Mertens, M.B. Wall, L. Roseman, L. Demetriou, D.J. Nutt, R.L. Carhart-Harris","journal":"European Neuropsychopharmacology","publication_date":"2019-12-01","publication_year":2019,"doi":"10.1016/j.euroneuro.2019.09.593","pubmed_id":null,"openalex_id":"https://openalex.org/W4248055189","source_url":"https://doi.org/10.1016/j.euroneuro.2019.09.593","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Treatment-Resistant Depression","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-02 20:42:13","last_checked":"2026-08-09 08:25:49","bibtex":null,"source_record_id":"DOI:10.1016/j.euroneuro.2019.09.593","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.euroneuro.2019.09.593","source_url":"https://doi.org/10.1016/j.euroneuro.2019.09.593","doi":"10.1016/j.euroneuro.2019.09.593","pmid":"","publication_date":"2019-12-01","importer_version":"2.1.3","text_redistributed":false}}],"total":187,"page":1,"per_page":20,"pages":10,"resource":"papers","filters":{"q":null,"author":"Robin Carhart-Harris","substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}